These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31642904)

  • 41. Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains.
    Bolger GB; Dunlop AJ; Meng D; Day JP; Klussmann E; Baillie GS; Adams DR; Houslay MD
    Cell Signal; 2015 Apr; 27(4):756-69. PubMed ID: 25546709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.
    Houslay MD; Baillie GS; Maurice DH
    Circ Res; 2007 Apr; 100(7):950-66. PubMed ID: 17431197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
    Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
    J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.
    Yang JX; Hsieh KC; Chen YL; Lee CK; Conti M; Chuang TH; Wu CP; Jin SC
    Sci Rep; 2017 Apr; 7():46165. PubMed ID: 28383060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphodiesterase inhibitors say NO to Alzheimer's disease.
    Nabavi SM; Talarek S; Listos J; Nabavi SF; Devi KP; Roberto de Oliveira M; Tewari D; Argüelles S; Mehrzadi S; Hosseinzadeh A; D'onofrio G; Orhan IE; Sureda A; Xu S; Momtaz S; Farzaei MH
    Food Chem Toxicol; 2019 Dec; 134():110822. PubMed ID: 31536753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.
    Houslay MD; Adams DR
    Biochem J; 2003 Feb; 370(Pt 1):1-18. PubMed ID: 12444918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.
    Delyon J; Servy A; Laugier F; André J; Ortonne N; Battistella M; Mourah S; Bensussan A; Lebbé C; Dumaz N
    Oncogene; 2017 Jun; 36(23):3252-3262. PubMed ID: 28092671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
    Tilley DG; Maurice DH
    Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Past, Present, and Future of Phosphodiesterase-4 Modulation for Age-Induced Memory Loss.
    Hansen RT; Zhang HT
    Adv Neurobiol; 2017; 17():169-199. PubMed ID: 28956333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple cAMP Phosphodiesterases Act Together to Prevent Premature Oocyte Meiosis and Ovulation.
    Vigone G; Shuhaibar LC; Egbert JR; Uliasz TF; Movsesian MA; Jaffe LA
    Endocrinology; 2018 May; 159(5):2142-2152. PubMed ID: 29608743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation.
    Ang KL; Antoni FA
    J Neurochem; 2002 May; 81(3):422-33. PubMed ID: 12065651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.
    Peter D; Jin SL; Conti M; Hatzelmann A; Zitt C
    J Immunol; 2007 Apr; 178(8):4820-31. PubMed ID: 17404263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice.
    Rutten K; Misner DL; Works M; Blokland A; Novak TJ; Santarelli L; Wallace TL
    Eur J Neurosci; 2008 Aug; 28(3):625-32. PubMed ID: 18702734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization.
    Pérez-Torres S; Cortés R; Tolnay M; Probst A; Palacios JM; Mengod G
    Exp Neurol; 2003 Aug; 182(2):322-34. PubMed ID: 12895443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.
    Richter W; Jin SL; Conti M
    Biochem J; 2005 Jun; 388(Pt 3):803-11. PubMed ID: 15717866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex.
    Schafer PH; Truzzi F; Parton A; Wu L; Kosek J; Zhang LH; Horan G; Saltari A; Quadri M; Lotti R; Marconi A; Pincelli C
    Cell Signal; 2016 Jul; 28(7):753-63. PubMed ID: 26806620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Citrus flavonoid 3,5,6,7,8,3',4'-heptamethoxyflavone induces BDNF via cAMP/ERK/CREB signaling and reduces phosphodiesterase activity in C6 cells.
    Sawamoto A; Okuyama S; Nakajima M; Furukawa Y
    Pharmacol Rep; 2019 Aug; 71(4):653-658. PubMed ID: 31195342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PDE4 and mAKAPβ are nodal organizers of β2-ARs nuclear PKA signalling in cardiac myocytes.
    Bedioune I; Lefebvre F; Lechêne P; Varin A; Domergue V; Kapiloff MS; Fischmeister R; Vandecasteele G
    Cardiovasc Res; 2018 Sep; 114(11):1499-1511. PubMed ID: 29733383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.